3rd Quarter - Report
RUBICON ADVISORS, LLC for DYNAVAX TECHNOLOGIES
Client
Income
$75,000
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Pharmacy PHA
Prescription User Fee, Biomedical Advance Research and Development Authority (BARDA)
| Lobbyist | Covered position, as disclosed |
|---|---|
| WILLIAM BURKE | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.